Frontiers in Immunology (Feb 2021)

In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection

  • Juliana de Melo Batista dos Santos,
  • Camila Pereira Soares,
  • Fernanda Rodrigues Monteiro,
  • Fernanda Rodrigues Monteiro,
  • Ralyria Mello,
  • Jonatas Bussador do Amaral,
  • Andressa Simões Aguiar,
  • Andressa Simões Aguiar,
  • Mariana Pereira Soledade,
  • Carolina Sucupira,
  • Milena De Paulis,
  • Juliana Bannwart Andrade,
  • Flavia Jaqueline Almeida,
  • Marco Aurélio Palazzi Sáfadi,
  • Luciana Becker Mau,
  • Jamile Menezes Brasil,
  • Theresa Ramalho,
  • Flávio V. Loures,
  • Rodolfo Paula Vieira,
  • Rodolfo Paula Vieira,
  • Rodolfo Paula Vieira,
  • Edison Luiz Durigon,
  • Edison Luiz Durigon,
  • Danielle Bruna Leal de Oliveira,
  • Danielle Bruna Leal de Oliveira,
  • André Luis Lacerda Bachi,
  • André Luis Lacerda Bachi

DOI
https://doi.org/10.3389/fimmu.2021.595343
Journal volume & issue
Vol. 12

Abstract

Read online

Likely as in other viral respiratory diseases, SARS-CoV-2 elicit a local immune response, which includes production and releasing of both cytokines and secretory immunoglobulin (SIgA). Therefore, in this study, we investigated the levels of specific-SIgA for SARS-CoV-2 and cytokines in the airways mucosa 37 patients who were suspected of COVID-19. According to the RT-PCR results, the patients were separated into three groups: negative for COVID-19 and other viruses (NEGS, n = 5); negative for COVID-19 but positive for the presence of other viruses (OTHERS, n = 5); and the positive for COVID-19 (COVID-19, n = 27). Higher specific-SIgA for SARS-CoV-2, IFN-β, and IFN-γ were found in the COVID-19 group than in the other groups. Increased IL-12p70 levels were observed in OTHERS group as compared to COVID-19 group. When the COVID-19 group was sub stratified according to the illness severity, significant differences and correlations were found for the same parameters described above comparing severe COVID-19 to the mild COVID-19 group and other non-COVID-19 groups. For the first time, significant differences are shown in the airway's mucosa immune responses in different groups of patients with or without respiratory SARS-CoV-2 infection.

Keywords